- US-listed companies
- REPLIGEN CORP
- Financials
- Cost of revenue
REPLIGEN CORPRGEN
Market cap
$8.9B
P/E ratio
| Period End | Cost of revenue (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | 360 | +1.66% |
| Dec 31, 2023 | 354 | +2.34% |
| Dec 31, 2022 | 346 | +23.83% |
| Dec 31, 2021 | 279 | +78.30% |
| Dec 31, 2020 | 157 | +31.52% |
| Dec 31, 2019 | 119 | +37.64% |
| Dec 31, 2018 | 87 | +29.05% |
| Dec 31, 2017 | 67 | +42.31% |
| Dec 31, 2016 | 47 | +33.66% |
| Dec 31, 2015 | 35 | +25.80% |
| Dec 31, 2014 | 28 | +24.65% |
| Dec 31, 2013 | 22 | -9.92% |
| Dec 31, 2012 | 25 | +383.94% |
| Dec 31, 2011 | 5 |